Postprandial Antihypertensive Evaluation of Microencapsulated Pomegranate Juice in Women With Mild Hypertension: A Randomized Pilot Study
International Journal of Hypertension · 2026-01 · 2026 (1)
DOI: 10.1155/ijhy/7665540 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hypertension, online erschienen am 02.04.2026. Verfasst von Gabriel Betanzos-Cabrera und 8 weiteren Autor:innen. Beteiligte Einrichtung: Área Académica de Nutrición, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Tilcuautla, 42080, Mexico, uaeh.edu.mx. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Hypertension is a risk factor for cardiovascular disease (CVD). Pomegranates are fruits with a high phenol content that have an antihypertensive effect.
Objective
This randomized postprandial pilot study evaluated microencapsulated pomegranate juice (MPJ) as a natural antihypertensive agent in patients with mild hypertension. Materials and Methods The content of phenols, flavonoids, anthocyanins, and antioxidant activity in fresh pomegranate juice (FPJ) and MPJ was determined. Subsequently, the postprandial antihypertensive effect was evaluated in recruited participants who consumed approximately a 480 kcal breakfast. Four experimental groups with five participants each were evaluated: FPJ, 150 mL fresh juice; MPJ, 20 g MPJ; the participant’s usual drug (AH); and 150 mL water (W) with breakfast. Each participant’s blood pressure (BP) was measured before and after breakfast at 30, 60, 90, and 120 min. Changes in BP values were evaluated as a function of time using generalized linear models.
Results
MPJ contained the highest content of phenols (14.84 ± 0.03 mg gallic acid equivalent/g lyophilized FPJ) and flavonoids (9.20 ± 0.50 mg quercetin equivalent/g lyophilized FPJ) compared to FPJ; the latter contained a higher content of anthocyanins (3.06 ± 0.009 mg cyanidin 3‐glucoside/g lyophilized FPJ) and had higher antioxidant capacity. In systolic BP, AH showed significant reductions at 60–120 min. Several statistically significant differences in diastolic pressure were observed: MPJ at 30–120 min and FPJ and AH groups at 60–120 min. FPJ exerted an effect similar to AH at 90 min.
Conclusions
The results suggest a moderate postprandial antihypertensive effect of MPJ when used as an adjunct to pharmacological treatment. However, the findings do not support its use as a replacement for antihypertensive therapy. Trial Registration: ClinicalTrials.gov identifier: NCT07017296
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Área Académica de Nutrición, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Tilcuautla, 42080, Mexico, uaeh.edu.mx.
- Departamento de Graduados, Instituto de Ciencias de la Salud, Universidad Autónoma Del Estado de Hidalgo, Tilcuautla, 42080, Mexico, uaeh.edu.mx.
- Departamento de Jurisdicción Sanitaria 2 Tulancingo de Bravo, Servicios de Salud de Hidalgo, Tulancingo de Bravo, 43600, Mexico.
- Departamento de Farmacología, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano No. 1 Col. Sección 16 Tlalpan, C.P, Ciudad de México, 14080, Mexico, cardiologia.org.mx.
- Departamento de Nutrición Animal y Bioquímica, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México Ciudad Universitaria, Coyoacán, 04510, Mexico, unam.mx.
- Área Académica de Nutrición y Salud, Colegio de Ciencias y Humanidades, Universidad Autónoma de la Ciudad de México, Iztapalapa, 09790, Mexico, uacm.edu.mx.
ORCID-Profile: Gabriel Betanzos-Cabrera, Perfecta Cabrera-García, Héctor Enrique Fabella-Illescas, Leonardo Del Valle-Mondragón, José Moisés Talamantes-Gómez, Néstor A Sánchez-Ortiz, José Alberto Ariza-Ortega, Deyanira Ojeda-Ramírez, Joy A Ahlgren-Beckendorf
Zitieren
APA
Betanzos-Cabrera, G., Cabrera-García, P., Fabella-Illescas, H. E., Valle-Mondragón, L. D., Talamantes-Gómez, J. M., Sánchez-Ortiz, N. A., Ariza-Ortega, J. A., Ojeda-Ramírez, D., & Ahlgren-Beckendorf, J. A. (2026). Postprandial Antihypertensive Evaluation of Microencapsulated Pomegranate Juice in Women With Mild Hypertension: A Randomized Pilot Study. International Journal of Hypertension, 2026(1). https://doi.org/10.1155/ijhy/7665540
Vancouver
Betanzos-Cabrera G, Cabrera-García P, Fabella-Illescas HE, Valle-Mondragón LD, Talamantes-Gómez JM, Sánchez-Ortiz NA, et al. Postprandial Antihypertensive Evaluation of Microencapsulated Pomegranate Juice in Women With Mild Hypertension: A Randomized Pilot Study. International Journal of Hypertension. 2026;2026(1). doi:10.1155/ijhy/7665540
BibTeX
@article{BetanzosCabrera2026,
author = {Betanzos-Cabrera, Gabriel and Cabrera-García, Perfecta and Fabella-Illescas, Héctor Enrique and Valle-Mondragón, Leonardo Del and Talamantes-Gómez, José Moisés and Sánchez-Ortiz, Néstor A and Ariza-Ortega, José Alberto and Ojeda-Ramírez, Deyanira and Ahlgren-Beckendorf, Joy A},
title = {Postprandial Antihypertensive Evaluation of Microencapsulated Pomegranate Juice in Women With Mild Hypertension: A Randomized Pilot Study},
journal = {International Journal of Hypertension},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijhy/7665540}
}
EUVIMED